Anika Therapeutics (ANIK) OCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | 8.40 | 4.41 | -1.79 | 5.40 | 11.2 | 6.47 | ||
| Changes by years, y/y, % | -36% | -47% | -141% | -402% | +107% | -3.1% | |||
Anika Therapeutics. OCF, bln rub
Anika Therapeutics. OCF, changes, %
Anika Therapeutics. OCF, sum by quarters, bln rub
Anika Therapeutics (ANIK) OCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| OCF, bln rub | ? | -0.130 | -0.189 | 6.87 | 4.64 | -4.85 | 6.47 | |
| Changes by years, y/y, % | +3% | -82% | +37% | +193% | +3 628% | |||
| Changes by quarters, q/q, % | -108% | +45% | -3 735% | -33% | -205% | |||